Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TD Tele-Doc Weight Loss vs VigorMeds

TD Tele-Doc Weight Loss
Graded #286

Higher grade

vs+10.099999999999994
VigorMeds
Graded #483

Lower grade

The verdict

TD Tele-Doc Weight Loss takes it — 61.8/100 to 51.7/100.

TD Tele-Doc Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TD Tele-Doc Weight Loss is a 100% virtual telehealth practice serving Virginia and Maryland that prescribes FDA-approved brand GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro) and compounded…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationTD Tele-Doc Weight Loss +13
53
40
Clinical oversightTD Tele-Doc Weight Loss +18
88
70
Labs & monitoringTD Tele-Doc Weight Loss +12
65
53
FulfillmentTD Tele-Doc Weight Loss +8
68
60
Contract termsTD Tele-Doc Weight Loss +14
55
41
TD Tele-Doc Weight Loss · left barVigorMeds · right bar

The numbers

MetricTD Tele-Doc Weight LossVigorMeds
WeighScore61.8/10051.7/100
GradeCC
Scorecard rank#286#483
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage2 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
TD Tele-Doc Weight Loss

Graded #286 · C

Strengths

  • Brand Wegovy/Zepbound AND compounded sema available; prescribing based on medical history and coverage
  • 100% virtual — weekly appointments with board-certified MDs from home; no travel required
  • Remote Patient Monitoring Starter Box: biometric scale + blood pressure cuff sync to care team in real time
  • In-network with most commercial insurance plans; may cover visits and monitoring equipment
  • Physician-led by Dr. Peter Wilbanks MD (30-yr OB/GYN, VCU) and Dr. Michael Perini MD (ABIM board-certified)

Where it loses points

  • No public cash pricing; cost entirely depends on insurance coverage — not viable for uninsured patients
  • Telehealth available only in Virginia and Maryland; no national reach confirmed
  • No Medicare or Medicaid accepted; limited to commercial insurance plans only
  • No LegitScript certification found; compounded availability and specific pricing undisclosed on site
  • Tirzepatide (Zepbound/Mounjaro) availability less prominent in MD pages; semaglutide is primary focus
VigorMeds

Graded #483 · C

Strengths

  • Provider-guided GLP-1 weight management via a telehealth consultation, not a pure async questionnaire
  • Care delivered by named, experienced clinicians (Dr. Anthony Kane, Dr. Kevin Kargman, Stephanie Kowatch FNP-C)
  • No-questions-asked 30-day satisfaction guarantee
  • Multi-vertical platform — also offers anti-aging/wellness, ED, and hair-loss treatment
  • Personalized treatment plan with ongoing follow-up and support

Where it loses points

  • Pricing not shown until you create an account and complete the intake
  • Specific GLP-1 medications and forms are not named on the public site
  • States served are not listed on an accessible page
  • Vigormeds LLC is a patient-management platform; prescribing is via OLA Health LLC and independent providers
  • No LegitScript certification or pharmacy-partner details published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard